Abstract The enteric nervous system (ENS) controls the function of the gastrointestinal tract and has been implicated in various diseases, including Parkinson's disease (PD). PD is a neurodegenerative disease with Lewy bodies (LBs) and Lewy neurites (LNs) as the main pathological features. In addition to the typical motor symptoms in PD, attention has been drawn to non-motor symptoms, such as constipation, implying dysfunction of the ENS. In the present study, we characterized the age-dependent morphological alterations and aggregation of a-synuclein (asyn), the primary protein component in LBs and LNs, in the ENS in an a-syn transgenic mouse model. We found that the expression and accumulation of a-syn increased gradually in neurons of Meissner's and Auerbach's plexuses of the gastrointestinal tract with age (from 1 week to 2 years). In addition, a-syn was increasingly phosphorylated at the serine 129 residue, reflecting pathological alterations of the protein over time. Furthermore, asyn was present in different subtypes of neurons expressing vasoactive intestinal polypeptide, neuronal nitric oxide synthase, or calretinin. The results indicated that BAC-aSyn-GFP transgenic mice provide a unique model in which to study the relationship between ENS and PD pathogenesis.
Introduction
Parkinson's disease (PD), a common neurodegenerative disorder, is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain, and the presence of Lewy bodies (LBs) and Lewy neurites (LNs) in remaining neurons. Alpha-synuclein (a-syn) is the primary protein component in LBs and LNs; it is enriched in presynaptic components under physiological conditions and appears as aggregated forms in PD [1] . Clinically, patients with PD exhibit typical motor symptoms, such as resting tremor, bradykinesia, and rigidity. At early stages of the disease, PD patients often exhibit non-motor symptoms, such as olfactory malfunction, constipation, depression, and dementia, which severely affect their quality of life [2] [3] [4] [5] . To date, the mechanisms underlying these non-motor symptoms have yet to be fully understood.
Constipation is a common early non-motor symptom of PD, implying gastrointestinal dysfunction. The majority (up to 80%) of PD patients suffer from gastrointestinal dysfunction [2] [3] [4] . Accumulating evidence has suggested that a-syn pathology is initiated in the periphery and spreads first to lower brain structures such as the dorsal motor nucleus of the vagus (DMNV) in the medulla oblongata and later to higher brain structures in a rostralcaudal fashion [6] .
The most convincing evidence comes from the postmortem histological studies conducted by Braak and colleagues, who demonstrated this topographic localization of Lewy pathology during disease progression. Braak also demonstrated that LBs appear in neurons of the gastric Meissner's plexus of PD patients [7] , further supporting the hypothesis of the periphery, specifically the enteric nervous system (ENS), as the initial structure affected during PD. The Lewy pathology spreads into the central nervous system and then to higher brain regions. Recently, we demonstrated that different forms of a-syn can indeed spread into the brain via the vagus nerve [8] and provided evidence of a link in the gut-brain axis, which has led to the proposition of prion-like mechanisms of propagation of asyn in PD and related disorders [9, 10] .
The ENS has been called the 'second brain', as enteric neurons independently control the secretion and motility of the gastrointestinal tract [11] . The ENS plays an important role in the pathogenic processes of PD [12] . Therefore, it is of current urgency to study the relationship between the ENS and the pathological development of PD. Here, we report the age-dependent presence, accumulation, and phosphorylation of a-syn in the enteric neurons of a BAC-a-Syn-GFP mouse model, which provides a unique tool in which to further study PD pathology in the ENS and beyond.
Materials and Methods

Mouse Strains
The BAC-a-Syn-GFP transgenic mice have been described elsewhere [13] . Briefly, the transgenic mice were produced by pronuclear injection of recombinant BAC (bacterial artificial chromosome) DNA containing the human a-syn gene fused with green fluorescent protein (GFP) into fertilized eggs from C57 black6 mice. BAC DNA is obtained by inserting human a-syn cDNA into the pAcGFP1-C1 vector at the initiation codon of mouse asyn gene [13] . The mice were housed five to six per cage under a 12 h light-dark cycle with ad libitum access to food and water. All work involving animals was approved by the Ethical Committees for use of laboratory animals at Lund University, Sweden, and at Northeastern University, China.
Tissue Preparation
BAC-a-Syn-GFP transgenic mice aged 1 week to 24 months (n = 3 at each age) were sacrificed by transcardial perfusion and fixation with 4% paraformaldehyde (PFA) in 0.1 mol/L PBS. The small intestine and colon were dissected, post-fixed in 4% PFA overnight, and then immersed consecutively in 10%, 20%, and 30% sucrose in 0.1 mol/L PBS. The intestine was cut transversely into 14-lm sections on a cryostat (Leica, Germany), and the sections were mounted on gelatin-coated glass slides for immunohistochemical processing.
Fluorescent Immunohistochemistry and Analyses
After antigen retrieval with citrate buffer (pH 6.0) for 10 min, the sections were pre-incubated with blocking solution containing 5% normal donkey serum and 0.3% Triton Fig. 1 Expression of a-syn in the small intestine of transgenic mice with age. Representative images of a-syn-GFP expression in the small intestine proximal to the stomach (left), the middle of the small intestine (middle), and the distal intestine (right) at 3, 6, 9, 18, and 24 months (m). Arrows, high-power images in insets; scale bar 250 lm.
X-100 in 0.1 mol/L PBS for 1 h. Double immunostaining was performed with primary antibodies (a-syn antibody (211) with respective double-labeling antibodies) ( Table 1) at room temperature overnight, followed by incubation with donkey anti-mouse, rabbit, or goat secondary antibodies tagged with Alexa-488, Cy2, or Cy3. The sections were mounted with an anti-fading medium for confocal microscopy (Leica TCS SP8). Semi-quantification of the asyn-transgenic-GFP and phospho-a-syn intensity was performed by measuring the fluorescence intensity of selected areas (at 4, 8, and 12 o'clock locations) of the intestinal sections. Two-way ANOVA and one-way ANOVA were used to analyze fluorescence intensity of a-syn and phospho-a-syn immunoreactivity, respectively, and all were followed by a Least Significant Difference (LSD) post hoc test in the software IBM SPSS Statistics 2.0 (IBM Svenska AB, Stockholm, Sweden). Logarithmic transformation was used when the variances of the statistics were not equal.
Results
Age-Dependent Presence and Accumulation of aSyn in Enteric Neurons of the Small Intestine
We first analyzed a-syn expression in the small intestine in the proximal (close to the stomach, i.e. the duodenum), middle, and distal (close to the colon) regions at different ages. a-Syn was barely present in the enteric neurons at 1 week and very scattered at one month. From three months onwards, an a-syn signal was detected and substantially increased with age. The high a-syn expression level was sustained in the oldest mice (Figs. 1, 2) . The expression of a-syn-GFP increased gradually. This is consistent with the protein expression in the brain, in which initial low expression can start at the late embryonic stage, but is more robust at 1 week after birth [8, 14] . The a-syn expression was significantly more robust in the distal than in the proximal small intestine. By 9 months of age, similar levels of a-syn were observed throughout the intestinal segments examined. a-Syn was first mainly located in the somata of enteric neurons in both Meissner's (submucosal) and Auerbach's (myenteric) plexuses at the younger age, and then became evident in the nerve processes extending to the tips of microvilli of the mucosa (Figs. 1, 3) .
Age-Dependent Phosphorylation of a-Syn in Enteric Neurons
Phosphorylation is one of the most common post-translational modifications to a-syn [15] , playing an important role in PD pathology. Therefore, we then focused on whether and how a-syn was phosphorylated in the enteric neurons of BAC a-syn-GFP mice. Using a phospho-a-syn antibody specific for the serine 129 residue we detected small amounts of phosphorylated a-syn in the enteric neurons of Meissner's and Auerbach's plexuses (Figs. 4, 5 ) Fig. 4 Age-dependent phosphorylation of a-syn in Meissner's plexus of the small intestine. Profiles of phospho-a-syn (P-a-syn, left), pana-syn (middle), and their co-localization (right), in 3, 9, and 24 month-old mice. The photomicrographs acquired under a confocal microscope show increased phosphorylation of a-syn with age (left). Subsets of pan-a-syn-positive profiles (middle) are overlapped with phospho-a-syn-positive profiles (right) (arrows and the insets). Scale bar 50 lm.
at 3 months of age. Compared to the pan-a-syn for the same age group, the signal of phospho-a-syn was much weaker. Semi-quantitative analyses showed that a-syn phosphorylation (pS129) became more evident with age (Fig. 6) . It was not only present in the cell bodies of enteric neurons, but also appeared in processes in the mucosal and muscular layers as well as in the nerve terminals around enteric neurons (Fig. 5) .
Localization of a-Syn in Subtypes of Enteric Neurons
There are multiple subtypes of neurons in the enteric nervous system that exert different functions, use different neurotransmitters, and behave differently in electrophysiological tests [16] . Considering this, we examined the localization of a-syn in different neuronal subtypes. Most calretinin-positive neurons in Auerbach's plexus of the mouse small intestine are excitatory motor neurons to the circular and longitudinal muscle layers [17] , innervating smooth muscles of the intestine. We observed an agedependent pattern of calretinin expression in the enteric neurons of both Meissner's and Auerbach's plexuses (Fig. 7B ), similar to a-syn. Calretinin expression was similar in amount among the proximal, middle, and distal segments of the small intestine (Fig. 7A) , with calretininpositive nerve terminals extending to the tips of the microvilli. It appeared that most, if not all, a-syn-positive profiles overlapped with calretinin, though a small fraction of calretinin-positive fibers and terminals did not express a-syn (Fig. 7B, C) . In contrast to calretinin, the majority of nNOS-positive neurons are inhibitory motor neurons to circular muscle [17] . We found that nNOS expression reached a plateau by 6 months of age and maintained a high level. Very interestingly, the protein expression was restricted to Meissner's and Auerbach's plexuses in the submucosal and muscular layers, and the nNOS-positive profiles barely extended into the mucosal layer and microvilli. The co-localization of a-syn and nNOS was evident mainly in Auerbach's plexus of the myenteric layers, while they were separate from each other in other regions (Fig. 8) . Vasoactive intestinal polypeptide (VIP)-positive profiles were widely distributed in the small intestine of transgenic mice. They were present in Meissner's and Auerbach's plexuses and the nerve fibers in different intestinal layers, without clear age-related alterations or differences among the proximal, middle, and distal segments of the intestine (Fig. 9) . We only observed partial co-localization between VIP and a-syn, much less than that between calretinin/nNOS and a-syn. In highpower images, VIP and a-syn immunoreactivity was largely separate (Fig. 9C) , indicating that they are localized in different subcellular compartments.
Discussion
Gastrointestinal dysfunction is a common non-motor symptom in PD. It can manifest as gastric dis-motility, constipation, or anorectal dysfunction [18, 19] . Considering the presence of Lewy pathology in the enteric neurons of the gut and then the DMNV in the medulla oblongata at very early stages of PD, mostly preceding the onset of the motor symptoms, Braak et al proposed that PD pathology is initiated in the gastrointestinal tract [20] , when the key protein component in LBs and LNs, a-syn, is aggregated in enteric neurons. Further studies using samples from biopsies and autopsies mostly favor the hypothesis of a link between the gut and the brain in PD pathogenesis [21] [22] [23] , despite inconsistency with other reports [24, 25] . The current opinion of gut-brain communication is that the Lewy pathology initiated in the enteric neurons of the gut undergoes a retrograde transport from the intestine up to the DMNV in the medulla oblongata, and further up to higher brain regions. Our recent study demonstrated that, when applying different forms of exogenous a-syn to the intestinal wall, the monomeric, oligomeric or fibrillar forms of a-syn are taken up and actively transported to the DMNV via the vagus nerve [8] . Truncal vagotomy interrupts the transport of aggregated a-syn, blocks the protein propagation and aggregation in the brain [26] , and decreases the risk of PD development [27] . Therefore, it is conceivable that, at least in subsets of PD cases, the origin of pathology is the enteric neurons of the gastrointestinal tract.
We here demonstrated an increase of a-syn presence and phosphorylation in enteric neurons with age. a-Syn Fig. 8 Expression of nNOS in the small intestine of transgenic mice with age and the co-localization of nNOS and a-syn. A Expression of nNOS in different sections (proximal, middle, and distal segments) of the intestine in transgenic mice. B a-Syn and nNOS expressed in transgenic mice and the co-localization at 3, 6, and 24 months. C Colocalization of nNOS and a-syn, and the nucleus of an enteric neuron at 24 months. Scale bars 200 lm in A, B; 10 lm in C. appeared in both excitatory (positive for calretinin) and inhibitory enteric motor neurons (positive for nNOS); therefore, it is likely that accumulated and aggregated asyn not only contributes to the spread of protein to the brain via the vagus, but also causes gastrointestinal dysfunction, leading to the gastrointestinal symptoms in PD. Available evidence has shown that increased intestinal permeability is associated with the presence of a-syn in the intestinal mucosa at the early stages of PD [28] .
What causes a-syn accumulation and aggregation in the enteric neurons is still not clear. In the present study, we demonstrated that normal development and aging can be a major contributing factor. Recent studies have also suggested that multiple risk factors may individually or jointly contribute to this, for example, gut microbiota [29] , intestinal inflammation [30] , and enteric glial cell dysfunction [31] . The results here provide evidence that the BAC a-syn-GFP transgenic mouse model is a useful tool in which to study a-syn accumulation, aggregation, and spread in enteric neurons in relation to gastrointestinal function and PD pathogenesis. Understanding how the pathology is initiated in the gut will help treat the gastrointestinal dysfunction and perhaps aid in preventing or delaying the onset and progression of PD. Fig. 9 Expression of VIP in the small intestine of transgenic mice with age and the co-localization of VIP and a-syn. A Expression of VIP in different sections (proximal, middle, and distal segments) of the small intestine in transgenic mice. B a-Syn and VIP expressed in transgenic mice and their co-localization at 6, 9, and 24 months. C Co-localization of VIP and a-syn, and the nucleus (DAPI) of an enteric neuron at 24 months. Scale bars 200 lm in A, B; 10 lm in C.
